Details
| Stereochemistry | MIXED |
| Molecular Formula | C14F24 |
| Molecular Weight | 624.1115 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(C1(F)F)C(F)(F)C(F)(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C23F
InChI
InChIKey=QKENRHXGDUPTEM-UHFFFAOYSA-N
InChI=1S/C14F24/c15-1-2(16)4(18,10(29,30)14(37,38)12(33,34)6(2,21)22)8(25,26)7(23,24)3(1,17)9(27,28)13(35,36)11(31,32)5(1,19)20
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Highly selective detection of silver in the low ppt range with ion-selective electrodes based on ionophore-doped fluorous membranes. | 2010-09-15 |
|
| A case of retinal detachment in colobomatous macrophthalmos with microcornea syndrome. | 2009-12 |
|
| Perfluorinated polycyclic aromatic hydrocarbons: anthracene, phenanthrene, pyrene, tetracene, chrysene, and triphenylene. | 2009-02-05 |
|
| Solvation of halogens in fluorous phases. Experimental and simulation data for F2, Cl2, and Br2 in several fluorinated liquids. | 2008-05-29 |
|
| Fluorophilic ionophores for potentiometric pH determinations with fluorous membranes of exceptional selectivity. | 2008-03-15 |
|
| Management of nucleus loss into the vitreous: long term follow up in 63 patients. | 2007-12 |
|
| Fluorous bulk membranes for potentiometric sensors with wide selectivity ranges: observation of exceptionally strong ion pair formation. | 2005-06-29 |
|
| Microbial growth in various perfluorocarbon liquids. | 2005-06-17 |
|
| In vitro effect of silicone oil and liquid perfluorocarbons on platelet aggregation. | 2005-01-11 |
|
| The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. | 2004-11 |
|
| Biocompatibility assessment of silicone oil and perfluorocarbon liquids used in retinal reattachment surgery in rat retinal cultures. | 2002-06-15 |
|
| Suprachoroidal hemorrhage as a complication of vitrectomy. | 2001-07-28 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
39423
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | |||
|
ZZ3T53GWV9
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | |||
|
1540875
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID1047029
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | |||
|
78972
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | |||
|
306-91-2
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY | |||
|
ZZ3T53GWV9
Created by
admin on Mon Mar 31 21:24:14 GMT 2025 , Edited by admin on Mon Mar 31 21:24:14 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
